Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific instrumentation, has been awarded the Silver Medal by EcoVadis, a globally recognized provider of business sustainability ratings. Wetzlar, Germany – Leica Microsystems, a Danaher company and a leading provider of microscopy and scientific instrumentation, has been awarded the Silver Medal by EcoVadis, a globally [...]

Mastermind® FLEX Data powers Compass Bioinformatics’s InheriNext® platform, bringing unparalleled genomic evidence to leading institutes across US, Japan, and beyond while advancing precision medicine globally Ann Arbor, MI, USA and Tokyo, Japan –  Genomenon, a leading genomic intelligence company, today announced a strategic partnership with Compass Bioinformatics, integrating Genomenon’s Mastermind FLEX Data into Compass Bioinformatic’s innovative [...]

LEIDEN, Netherlands -- Ncardia, a leader in stem cell–based solutions for drug discovery and safety assessment, today announced the launch of Ncyte® NHP-C vCardiomyocytes, the first commercially available ventricular-like cardiomyocytes derived from induced pluripotent stem cells (iPSCs) of cynomolgus monkeys. New Ncyte® NHP-C vCardiomyocytes provide a scalable, ethical and translational tool for cross-species cardiac studies. The [...]

Waddinxveen (NL) -- INTEGRA Biosciences Group, a leading provider of laboratory tools for liquid handling and media preparation based in Switzerland, is buying shares in CleanNA, an established reagent manufacturer based in the Netherlands. This initial investment will cement a long-term strategic collaboration between the two companies, with a view to expanding CleanNA’s global reach and [...]

First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expression Portfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elements Sheffield, UK -- SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, [...]

Oxford, UK -- Hitachi High-Tech Analytical Science Corporation (Hitachi High-Tech Analytical Science), a Hitachi High-Technologies Corporation (TSE: 8036) wholly owned subsidiary engaged in the manufacture and sales of analysis and measuring instruments, today introduces the new FT160 XRF analyzer with three base configuration options for the analysis of nanometer scale coatings. Following the introduction of [...]

BioFlyte Partners with Los Alamos National Laboratory to Optimize Modeling and Simulation Tools for Biothreat Detection and Response ALBUQUERQUE, N.M. – BioFlyte, a chemical and bioaerosol surveillance firm with a disruptive new class of fieldable chemical and biological threat collection, detection, and identification solutions, today announced a new collaboration with Los Alamos National Laboratory (LANL) as [...]

Brno, Czech Republic — Tescan Group today announced the acquisition of FemtoInnovations, a leading innovator in ultrafast laser technologies, and the creation of a dedicated Laser Technology Business Unit (LT BU) headquartered at the University of Connecticut (UConn) Tech Park. The new unit expands Tescan’s correlative and multimodal portfolio for semiconductor, biomedical device manufacturing, and [...]

Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the TruSight™ Oncology (TSO) Comprehensive genomic profiling test. The continued expansion of tumor-agnostic CDx claims underscores Illumina's commitment to advance access for [...]

SALT LAKE CITY and BOSTON -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad's advanced laboratory capabilities in the [...]